Cue Health Stock

Cue Health EBIT

The EBIT of Cue Health (HLTHQ) as of Aug 7, 2026 is -296.71 M USD. In the previous year, EBIT was -203.70 M USD — a change of 45.66% (lower).

EBIT

-296.71 MUSD

YoY

45.66%

Last updated:

In 2026, Cue Health's EBIT was -296.71 M USD, a 45.66% increase from the -203.70 M USD EBIT recorded in the previous year.

The Cue Health EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2019
-20.80 base
Jan 1, 2020
-45.10 base
Jan 1, 2021
190.20 base
Jan 1, 2022
-203.70 base
Jan 1, 2023
-296.71 base
Jan 1, 2024 (e)
-232.13 base
Jan 1, 2025 (e)
-184.89 base
Jan 1, 2026 (e)
-113.16 base
YEAREBIT (M USD)
2026 est -113.16
2025 est -184.89
2024 est -232.13
2023 -296.71
2022 -203.70
2021 190.20
2020 -45.10
2019 -20.80
Access this data via the Eulerpool API

Cue Health Revenue

Cue Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
6.60 M USD
-20.80 M USD
-20.60 M USD
Jan 1, 2020
23.00 M USD
-45.10 M USD
-47.40 M USD
Jan 1, 2021
618.10 M USD
190.20 M USD
86.40 M USD
Jan 1, 2022
483.50 M USD
-203.70 M USD
-194.10 M USD
Jan 1, 2023
70.94 M USD
-296.71 M USD
-373.46 M USD
Jan 1, 2024 (e)
58.69 M USD
-232.13 M USD
-179.70 M USD
Jan 1, 2025 (e)
113.08 M USD
-184.89 M USD
-106.51 M USD
Jan 1, 2026 (e)
213.56 M USD
-113.16 M USD
-33.59 M USD

Cue Health Margins

Cue Health stock margins

The Cue Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cue Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cue Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
100.00 %
-315.15 %
-312.12 %
Jan 1, 2020
34.78 %
-196.09 %
-206.09 %
Jan 1, 2021
55.27 %
30.77 %
13.98 %
Jan 1, 2022
31.75 %
-42.13 %
-40.14 %
Jan 1, 2023
-79.16 %
-418.28 %
-526.48 %
Jan 1, 2024 (e)
-79.16 %
-395.50 %
-306.18 %
Jan 1, 2025 (e)
-79.16 %
-163.51 %
-94.19 %
Jan 1, 2026 (e)
-79.16 %
-52.99 %
-15.73 %

Cue Health Stock analysis

What does Cue Health do? Cue Health Inc. is a San Diego-based company specialized in the development and distribution of smart, mobile diagnostic devices. The company was founded in 2010 by Ayub Khattak and Dan Sullivan and has since expanded into various sectors. Cue Health's main business is the development of diagnostic devices that allow end-users to quickly and easily perform diagnostic tests. With a handheld device and proprietary software, customers can perform a wide range of tests in many areas, including tests for flu, colds, inflammatory diseases, sexually transmitted diseases, and COVID-19. Cue Health's business model is based on the idea of providing user-friendliness and portability in the field of diagnostics. With the technology, patients can independently perform diagnostic tests without having to visit a doctor. This not only saves time but also reduces costs for the customer. Since its founding, Cue Health has expanded into several sectors. In addition to the handheld diagnostic device, the company also offers solutions for the healthcare services sector. Through partnerships with biotech companies and medical institutions, the company assists in the development and marketing of diagnostic tests. An important part of Cue Health's history is the development of COVID-19 tests. The company quickly responded to develop a solution for COVID-19 tests that are both safe and easier to use. The Cue COVID-19 Test Kit complies with the requirements of the US Food and Drug Administration and is used in the USA. The test only requires a simple nasal swab, which is then inserted into the handheld device. Within minutes, the user receives the test result. Cue Health intends to continue expanding its technology to offer users a wider range of diagnostic test solutions. The previous tests have shown that the company is capable of delivering innovative solutions to the diagnostics market. The ability to receive fast, accurate, and affordable diagnostic solutions is invaluable for many people, especially those in hard-to-reach locations and without direct access to medical professionals. Overall, Cue Health is a highly innovative company specializing in excellent diagnostic technology and products for the healthcare industry. The products and services of Cue Health have the potential to revolutionize healthcare for all by making diagnostic tests safer, faster, and more convenient. Cue Health is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Cue Health's EBIT

Cue Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Cue Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Cue Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Cue Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Cue Health stock

EBIT of Cue Health is -296.71 M USD in 2026.

EBIT of Cue Health changed from -203.70 M USD to -296.71 M USD, representing a 45.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Cue Health since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Cue Health historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Cue Health

All Key Metrics — Cue Health